ClinicalTrials.Veeva

Menu

Antidiabetic Properties of Rose Hip

L

Lund University

Status

Completed

Conditions

Obesity

Treatments

Dietary Supplement: Rose hip

Study type

Interventional

Funder types

Other

Identifiers

NCT01316016
LUAFC002

Details and patient eligibility

About

The purpose of this study is to determine whether daily intake of a drink containing rose hip powder reduces risk markers of type diabetes and cardiovascular disease.

Enrollment

31 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • BMI > 30
  • willingness to participate in the study
  • willingness to comply with the daily intake of drinks and the recommended energy intake during the course of the study

Exclusion criteria

  • diabetes
  • previous or ongoing insulin treatment
  • abnormal thyroid status
  • abnormal liver status
  • abnormal kidney status
  • known gastrointestinal disorder
  • pregnancy
  • suspected allergy to ingredients of the drinks

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

31 participants in 1 patient group

Rose hip
Experimental group
Treatment:
Dietary Supplement: Rose hip

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems